Key facts
- It has raised $5.4M across 1 recorded rounds; the latest was Early Stage VC ($5.4M) in Oct 2022.
- Notable investors include Monte Carlo Capital, Proton Enterprises, Ikove, John D'Orazio.
- Atreon Orthopedics has filed 4 Form Ds with the SEC since 2022, most recently Jan 2026 ($5.4M sold to 58 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Atreon Orthopedics
Funding rounds
1 roundsAbout Atreon Orthopedics
Developer of orthopedic devices designed to accelerate and enhance the quality of repair at the site of a soft tissue injury. The company's products provide a structure for enhanced healing of sports medicine injuries, including tendon ruptures and tears, and the device is a non-woven, microfiber matrix comprising biodegradable polymer fiber that mimics the extracellular matrix structure found naturally in the body, enabling patients encountering sports medicine injuries to get bone healing and speedy recovery.
- Sector
- Healthcare
- HQ
- Dublin, OH, United States
- Founded
- 2016
- Employees
- 10
- Website
- atreonortho.com/
- Ownership
- Privately Held (backing)
Atreon Orthopedics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Atreon Orthopedics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Atreon Orthopedics in its N-PORT filings yet. We sweep new filings monthly.